Marom R, Rabenhorst BM, Morello R (2020) Osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol 183(4):R95–R106
CAS PubMed PubMed Central Article Google Scholar
Tournis S, Dede AD (2018) Osteogenesis imperfecta—a clinical update. Metabolism 80:27–37
CAS PubMed Article Google Scholar
Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, Montpetit K, Semler O (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052
Forlino A, Marini JC (2016) Osteogenesis imperfecta. Lancet 387(10028):1657–1671
CAS Article PubMed Google Scholar
Chetty M, Roomaney IA, Beighton P (2021) The evolution of the nosology of osteogenesis imperfecta. Clin Genet 99(1):42–52
CAS PubMed Article Google Scholar
Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16(2):101–116
CAS PubMed PubMed Central Article Google Scholar
van Dijk FS, Semler O, Etich J, Köhler A, Jimenez-Estrada JA, Bravenboer N, Claeys L, Riesebos E, Gegic S, Piersma SR, Jimenez CR, Waisfisz Q, Flores CL, Nevado J, Harsevoort AJ, Janus GJM, Franken AAM, van der Sar AM, Meijers-Heijboer H, Heath KE, Lapunzina P, Nikkels PGJ, Santen GWE, Nüchel J, Plomann M, Wagener R, Rehberg M, Hoyer-Kuhn H, Eekhoff EMW, Pals G, Mörgelin M, Newstead S, Wilson BT, Ruiz-Perez VL, Maugeri A, Netzer C, Zaucke F, Micha D (2020) Interaction between KDELR2 and HSP47 as a key determinant in osteogenesis imperfecta caused by Bi-allelic variants in KDELR2. Am J Hum Genet 107(5):989–999
PubMed PubMed Central Article CAS Google Scholar
Van Dijk FS, Sillence DO (2014) Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 164A(6):1470–1481
Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL, Robertson S, Savarirayan R, Sillence D, Spranger J, Unger S, Zabel B, Superti-Furga A (2011) Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 155A(5):943–968
PubMed Article CAS Google Scholar
Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, Nishimura G, Robertson S, Sangiorgi L, Savarirayan R, Sillence D, Superti-Furga A, Unger S, Warman ML (2019) Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A 179(12):2393–2419
Lim J, Grafe I, Alexander S, Lee B (2017) Genetic causes and mechanisms of Osteogenesis Imperfecta. Bone 102:40–49
CAS PubMed PubMed Central Article Google Scholar
O’Brien CA, Morello R (2018) Modeling rare bone diseases in animals. Curr Osteoporos Rep 16(4):458–465
PubMed PubMed Central Article Google Scholar
Rossi V, Lee B, Marom R (2019) Osteogenesis imperfecta: advancements in genetics and treatment. Curr Opin Pediatr 31(6):708–715
CAS PubMed PubMed Central Article Google Scholar
Enderli TA, Burtch SR, Templet JN, Carriero A (2016) Animal models of osteogenesis imperfecta: applications in clinical research. Orthop Res Rev 8:41–55
PubMed PubMed Central Google Scholar
Elefteriou F, Yang X (2011) Genetic mouse models for bone studies–strengths and limitations. Bone 49(6):1242–1254
CAS PubMed PubMed Central Article Google Scholar
Campbell BG, Wootton JA, Macleod JN, Minor RR (2001) Canine COL1A2 mutation resulting in C-terminal truncation of pro-alpha2(I) and severe osteogenesis imperfecta. J Bone Miner Res 16(6):1147–1153
CAS PubMed Article Google Scholar
Dietrich K, Fiedler IA, Kurzyukova A, López-Delgado AC, McGowan LM, Geurtzen K, Hammond CL, Busse B, Knopf F (2021) Skeletal biology and disease modeling in zebrafish. J Bone Miner Res 36(3):436–458
CAS PubMed Article Google Scholar
Marí-Beffa M, Mesa-Román AB, Duran I (2021) Zebrafish models for human skeletal disorders. Front Genet 12:675331
PubMed PubMed Central Article CAS Google Scholar
Bergen DJM, Kague E, Hammond CL (2019) Zebrafish as an emerging model for osteoporosis: a primary testing platform for screening new osteo-active compounds. Front Endocrinol (Lausanne) 10:6
Tonelli F, Bek JW, Besio R, De Clercq A, Leoni L, Salmon P, Coucke PJ, Willaert A, Forlino A (2020) Zebrafish: a resourceful vertebrate model to investigate skeletal disorders. Front Endocrinol (Lausanne) 11:489
PubMed Central Article Google Scholar
Gistelinck C, Gioia R, Gagliardi A, Tonelli F, Marchese L, Bianchi L, Landi C, Bini L, Huysseune A, Witten PE, Staes A, Gevaert K, De Rocker N, Menten B, Malfait F, Leikin S, Carra S, Tenni R, Rossi A, De Paepe A, Coucke P, Willaert A, Forlino A (2016) Zebrafish collagen Type I: molecular and biochemical characterization of the major structural protein in bone and skin. Sci Rep 6:21540
CAS PubMed PubMed Central Article Google Scholar
Gistelinck C, Kwon RY, Malfait F, Symoens S, Harris MP, Henke K, Hawkins MB, Fisher S, Sips P, Guillemyn B, Bek JW, Vermassen P, De Saffel H, Witten PE, Weis M, De Paepe A, Eyre DR, Willaert A, Coucke PJ (2018) Zebrafish type I collagen mutants faithfully recapitulate human type I collagenopathies. Proc Natl Acad Sci USA 115(34):E8037–E8046
CAS PubMed PubMed Central Article Google Scholar
Mienaltowski MJ, Gonzales NL, Beall JM, Pechanec MY (2021) Basic structure, physiology, and biochemistry of connective tissues and extracellular matrix collagens. Adv Exp Med Biol 1348:5–43
Schnieke A, Harbers K, Jaenisch R (1983) Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene. Nature 304(5924):315–320
CAS PubMed Article Google Scholar
Bonadio J, Saunders TL, Tsai E, Goldstein SA, Morris-Wiman J, Brinkley L, Dolan DF, Altschuler RA, Hawkins JE Jr, Bateman JF et al (1990) Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci USA 87(18):7145–7149
CAS PubMed PubMed Central Article Google Scholar
Hartung S, Jaenisch R, Breindl M (1986) Retrovirus insertion inactivates mouse alpha 1(I) collagen gene by blocking initiation of transcription. Nature 320(6060):365–367
CAS PubMed Article Google Scholar
Bonadio J, Jepsen KJ, Mansoura MK, Jaenisch R, Kuhn JL, Goldstein SA (1993) A murine skeletal adaptation that significantly increases cortical bone mechanical properties. Implications for human skeletal fragility. J Clin Invest 92(4):1697–1705
CAS PubMed PubMed Central Article Google Scholar
Stacey A, Bateman J, Choi T, Mascara T, Cole W, Jaenisch R (1988) Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene. Nature 332(6160):131–136
CAS PubMed Article Google Scholar
Pereira R, Khillan JS, Helminen HJ, Hume EL, Prockop DJ (1993) Transgenic mice expressing a partially deleted gene for type I procollagen (COL1A1) A breeding line with a phenotype of spontaneous fractures and decreased bone collagen and mineral. J Clin Invest 91(2):709–716
CAS PubMed PubMed Central Article Google Scholar
Pereira RF, O’Hara MD, Laptev AV, Halford KW, Pollard MD, Class R, Simon D, Livezey K, Prockop DJ (1998) Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A 95(3):1142–1147
CAS PubMed PubMed Central Article Google Scholar
Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC (1999) Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J Biol Chem 274(53):37923–37931
CAS PubMed Article Google Scholar
Kozloff KM, Carden A, Bergwitz C, Forlino A, Uveges TE, Morris MD, Marini JC, Goldstein SA (2004) Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res 19(4):614–622
Kozloff KM, Carden A, Bergwitz C, Forlino A, Uveges TE, Morris MD, Marini JC, Goldstein SA (2004) Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res 19(4):614–622Uveges TE, Kozloff KM, Ty JM, Ledgard F, Raggio CL, Gronowicz G, Goldstein SA, Marini JC (2009) Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation. J Bone Miner Res 24(5):849–59
Sinder BP, Salemi JD, Ominsky MS, Caird MS, Marini JC, Kozloff KM (2014) Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment. Bone 71:115–123
PubMed PubMed Central Article CAS Google Scholar
Sinder BP, White LE, Salemi JD, Ominsky MS, Caird MS, Marini JC, Kozloff KM (2014) Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength. Osteoporos Int 25(8):2097–2107
CAS PubMed PubMed Central Article Google Scholar
Panaroni C, Gioia R, Lupi A, Besio R, Goldstein SA, Kreider J, Leikin S, Vera JC, Mertz EL, Perilli E, Baruffaldi F, Villa I, Farina A, Casasco M, Cetta G, Rossi A, Frattini A, Marini JC, Vezzoni P, Forlino A (2009) In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 114(2):459–468
留言 (0)